Remote programming has significant advantages over conventional programming methods on some issues. This research will test the safety of SceneRay remote and wireless DBS programming system.
Programming is a crucial aspect of deep brain stimulation (DBS), directly influences the final success of DBS. Optimal programming helps patients achieve maximized control of clinical symptoms and higher life quality. However, there are a number of inadequacies in conventional programming methods. First, the programming probe must come into close contact with the implantable pulse generator (IPG) and test stimulator to complete programming. And during initial postoperative programming, only the parameters of one patient can be ascertained. In addition, the same frequency is typically used in the left and right brain for dual channel IPG. The patient also need to repeatedly travel between their home and the hospital, leading to increased time and expense. Therefore, the investigators developed the SceneRay wireless and remote DBS system to address the outline issues. This system has significant advantages over conventional programming methods on all the issues above. This research will test the safety of this remote and wireless DBS programming system.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Implement therapeutic programming in patients with network coverage at home
Shanghai Ruijin Hospital Functional Neurosurgery
Shanghai, Shanghai Municipality, China
The Unified Parkinson's Disease Rating Scale III&IV
Time frame: Through study completion, an average of 4 months
Deep Brain Stimulation Programming parameter
Contact selection
Time frame: Through study completion, an average of 4 months
Deep Brain Stimulation Programming parameter
Pulse width
Time frame: Through study completion, an average of 4 months
Deep Brain Stimulation Programming parameter
Frequency
Time frame: Through study completion, an average of 4 months
Deep Brain Stimulation Programming parameter
Amplitude
Time frame: Through study completion, an average of 4 months
Serious Adverse Event
Time frame: Through study completion, an average of 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.